These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20225039)

  • 1. Lentivirus-based virus-like particles as a new protein delivery tool.
    Muratori C; Bona R; Federico M
    Methods Mol Biol; 2010; 614():111-24. PubMed ID: 20225039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell death induced by the herpes simplex virus-1 thymidine kinase delivered by human immunodeficiency virus-1-based virus-like particles.
    Peretti S; Schiavoni I; Pugliese K; Federico M
    Mol Ther; 2005 Dec; 12(6):1185-96. PubMed ID: 16095973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A strategy of antigen incorporation into exosomes: comparing cross-presentation levels of antigens delivered by engineered exosomes and by lentiviral virus-like particles.
    Lattanzi L; Federico M
    Vaccine; 2012 Nov; 30(50):7229-37. PubMed ID: 23099330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective elimination of HIV-1-infected cells by Env-directed, HIV-1-based virus-like particles.
    Peretti S; Schiavoni I; Pugliese K; Federico M
    Virology; 2006 Feb; 345(1):115-26. PubMed ID: 16271741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploiting the yeast L-A viral capsid for the in vivo assembly of chimeric VLPs as platform in vaccine development and foreign protein expression.
    Powilleit F; Breinig T; Schmitt MJ
    PLoS One; 2007 May; 2(5):e415. PubMed ID: 17476337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein.
    Di Bonito P; Grasso F; Mochi S; Petrone L; Fanales-Belasio E; Mei A; Cesolini A; Laconi G; Conrad H; Bernhard H; Dembek CJ; Cosma A; Santini SM; Lapenta C; Donati S; Muratori C; Giorgi C; Federico M
    Virology; 2009 Dec; 395(1):45-55. PubMed ID: 19800648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain.
    Deml L; Kratochwil G; Osterrieder N; Knüchel R; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):10-25. PubMed ID: 9300033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of virus-like particles for gene transfer.
    Petry H; Goldmann C; Ast O; Lüke W
    Curr Opin Mol Ther; 2003 Oct; 5(5):524-8. PubMed ID: 14601522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY; Luo L; Wainberg MA; Li Y
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and characterization of recombinant VLPs and Semliki-Forest virus live vectors for comparative evaluation in the SHIV monkey model.
    Notka F; Stahl-Hennig C; Dittmer U; Wolf H; Wagner R
    Biol Chem; 1999 Mar; 380(3):341-52. PubMed ID: 10223337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo.
    Zhao J; Pettigrew GJ; Thomas J; Vandenberg JI; Delriviere L; Bolton EM; Carmichael A; Martin JL; Marber MS; Lever AM
    Basic Res Cardiol; 2002 Sep; 97(5):348-58. PubMed ID: 12200634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT; Boo I; Drummer HE; Netter HJ
    Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors.
    Kafri T; Blömer U; Peterson DA; Gage FH; Verma IM
    Nat Genet; 1997 Nov; 17(3):314-7. PubMed ID: 9354796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope.
    Haglund K; Forman J; Kräusslich HG; Rose JK
    Virology; 2000 Mar; 268(1):112-21. PubMed ID: 10683333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillomavirus virus-like particles as vehicles for the delivery of epitopes or genes.
    Xu YF; Zhang YQ; Xu XM; Song GX
    Arch Virol; 2006 Nov; 151(11):2133-48. PubMed ID: 16791442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.
    Yamada K; Olsen JC; Patel M; Rao KW; Walsh CE
    Mol Ther; 2001 Apr; 3(4):485-90. PubMed ID: 11319908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular construction of bionanoparticles: chimaeric SIV p17-HIV I p6 nanoparticles with minimal viral protein content.
    Costa MJ; Pedro L; de Matos AP; Aires-Barros MR; Belo JA; Goncalves J; Ferreira GN
    Biotechnol Appl Biochem; 2007 Sep; 48(Pt 1):35-43. PubMed ID: 17391101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus-like particles: designing an effective AIDS vaccine.
    Young KR; McBurney SP; Karkhanis LU; Ross TM
    Methods; 2006 Sep; 40(1):98-117. PubMed ID: 16997718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of multicistronic HIV-1 based lentiviral vectors.
    Chinnasamy N; Shaffer J; Chinnasamy D
    Methods Mol Biol; 2009; 515():137-50. PubMed ID: 19378113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillomavirus virus-like particles for the delivery of multiple cytotoxic T cell epitopes.
    Liu WJ; Liu XS; Zhao KN; Leggatt GR; Frazer IH
    Virology; 2000 Aug; 273(2):374-82. PubMed ID: 10915608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.